Clinical Trials Browser

Phase 2 × Breast Cancer Invasive × Clear all

NCT06695039 2025-12-02

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

Phase 2 Completed

Breast Cancer Invasive

NCT03627988 2025-07-31

MARTA

Phase 2 Active not recruiting

Breast Cancer Invasive

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Active not recruiting

Breast Cancer Invasive